REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
25/07/2026
Voltar para busca
Dado oficial do USPTO
Q2 SOLUTIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000086680061Classe
9, 35, 41, 42, 44, 45
Pedido
86680061
Registro
5251668
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
25/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 35, 41, 42, 44, 45
Data de depósito
01/07/2015
Data de registro
25/07/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/08/2024
Última transação
25/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
02/07/2015
Primeiro uso no comércio
02/07/2015
Código do desenho
5
Tipo de titular
16
Localização do titular
Durham, NC, US
Examinador
MAYES, LAURIE ANN
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the letter "Q" followed by a superscript number "2" followed by the word "Solutions".
Titulares e representantes
Titulares
Q Squared Solutions Holdings LLC
Q Squared Solutions Holdings LLC
Representantes
Arlene D. Hanks Moore & Van Allen PLLC
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 41Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer software for providingmanaging and analyzing laboratory clinical trial data and laboratory and clinical trials information in the fields of pharmaceuticalpharmacogenomicbiomarkerbiopharmaceuticalmedical device and diagnosticslife sciencesmedicalhealth carehealth management and disease management fields; computer software that allows remote access to clinical trial laboratory data and laboratory and clinical trials information; computer software for use in collecting and reporting medical data relating to patient medical conditions for clinical trialsresearchperi- and post-approval studiesquality improvementpatient support programs; none of the foregoing for use in the field of Medicare
Classe 35
Computerized database management and data processing services in the pharmaceuticalpharmacogenomicbiomarkerbiopharmaceuticalmedical device and diagnostics fields; providing business informationinformation related to regulatory approval and marketing of drugsdeviceshealth care or medical products and servicesbiologics; business research in the field of health care; business consultation in the field of healthcare; business technology consultingbusiness consulting services relating to the integration of the areas of business process technologychange management and operational sustainability in the healthcaremedicalhealth management and disease management fields; none of the foregoing for use in the field of Medicare
Classe 41
Educational and training servicesconducting training programsseminarsclassesconferences and workshops in the fields of health policyhealth managementdisease managementpatient managementpharmaceuticalpharmacogenomicbiomarkermedical device and diagnosticsdistributing course materials in connection therewith; teaching and training in information technology for the healthcare industry; all of the foregoing relating to clinical trialsclinical researchmedical and scientific laboratory servicesbiopharmaceuticalbiomarkerdiagnostics and medical product and device developmentresearchtestingregulatory approval and commercialization of diagnosticsbiopharmaceuticalsbiomarkers and medical products and devices and none of the foregoing for use in the field of or related to Medicare or other governmental health programs
Classe 42
Clinical research and testing servicesin the fields of clinical trialshealth care productspharmaceutical productspharmacogenomics productsbiomarker productsbiopharmaceutical productsmedical devices and diagnostics products; product development consultation in the fields of health caremedical products and devices; health care research and product development services; medical and laboratory testing services for research purposes; laboratory testing services for research purposes in the fields of health careclinical trialspharmaceuticalpharmacogenomicsbiomarkerbiopharmaceuticalmedical device and diagnostics; consultancy in the designplanning and implementation project management of clinical trials; health care medical research consultancy; product development consultancy in the fields of medical diagnosticsmedical devicespharmacologypharmacogenomicsbiomarkers and biopharmaceutical research; managingmonitoringcoordinating and implementing clinical studies being clinical trials on human subjects for others for research purposes; medical and scientific research in the fields of healthcare and medical diagnostics; providing temporary use of non-downloadableweb-based software application for providing access to information and data in the clinical trialspharmaceuticalpharmacogenomicbiomarkerbiopharmaceuticalmedical device and diagnosticslife scienceshealth management and disease management fields and for organizing and analyzing said data and information and preparing reports therefromproviding temporary use of non-downloadable software for providingmanaging and analyzing laboratory clinical trial data and information in the fields of pharmaceuticalpharmacogenomicbiomarkerbiopharmaceuticalmedical device and diagnosticslife scienceshealth management and disease management fields; providing temporary use of non-downloadable software that allows remote access to clinical trial peri- and post-approval laboratory data and information; providing temporary use of non-downloadable software for use in collecting and reporting medical data relating to patient medical conditions for research; providing scientific and medical research information relating to the development and validation of drugspharmaceutical productsmedical productsmedical devices and biologics; providing an internet website portal featuring scientific and medical research information in the fields of clinical trialspharmaceutical researchpharmacogenomic and biomarker consultationbiopharmaceutical consultationmedical devices and diagnosticslife sciences researchmedical research; providing an online searchable database via the internet featuring medical and scientific research information in the fields of clinical trialscompanion diagnosticspharmaceutical researchpharmacogenomic and biomarkersbiopharmaceuticalsmedical devices and diagnosticslife sciences researchmedical research; all of the foregoing relating to clinical trialsclinical researchmedical and scientific laboratory servicesbiopharmaceuticalbiomarkerdiagnostics and medical product and device developmentresearchtestingregulatory approval and commercialization of diagnosticsbiopharmaceuticalsbiomarkers and medical products and devices and none of the foregoing for use in the field of or related to Medicare or other governmental health programs
Classe 44
Providing health and medical information; providing pharmaceutical information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; providing medical information relating to pharmacogenomics and biomarkers; health management and disease management medical information to others; medical evaluation services; medical consulting services in the fields of health caremedicinelife sciencespharmaceuticalsbiopharmaceuticalsbiomarkerspharmacogenomicsmedical device and diagnostics; providing an online interactive computer database in the field of healthcare featuring healthcare information; providing an Internet website portal featuring medical and healthcare information in the fields of medical serviceshealth carehealth management and disease management; providing an online searchable database via the internet featuring medical and healthcare information in the fields of medical servicesmedical devices and diagnosticshealth carehealth management and disease management; none of the foregoing for use in the field of Medicare
Classe 45
Regulatory compliance research and consulting services in the fields of health careclinical trialsdevelopment and testing of drugsdevicesbiologics and methodologies used in the pharmaceutical industrybiotechnology industry and the medical device and diagnostics industry; conducting regulatory compliance audits for others in the fields of health careclinical trialspharmaceuticalpharmacogenomicbiomarkerbiopharmaceuticalmedical device and diagnostics; consulting services in the fields of regulatory affairsregulatory compliance consulting in the field of prescription drug sampling; manufacturing compliance and validation proceduresreviewing standards and practices to assure compliance with clinical trial regulationsmedical and laboratory testing services; providing regulatory informationproviding regulatory compliance information regarding the examination and approval process of pharmaceuticalbiotechnicalmedical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory compliance consulting services relating to the development and validation of drugsdevices and biologicsassisting others in implementing procedures that comply with regulatory requirements; none of the foregoing for use in the field of Medicare
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/08/2024
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/08/2024
E815
TEAS SECTION 8 & 15 RECEIVED
25/01/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
25/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/12/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
25/07/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21/06/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
20/06/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/06/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/06/2017
IUAF
USE AMENDMENT FILED
10/05/2017
EISU
TEAS STATEMENT OF USE RECEIVED
10/05/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
29/11/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/10/2016
PUBO
PUBLISHED FOR OPPOSITION
04/10/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/09/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/08/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/08/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
18/08/2016
ALIE
ASSIGNED TO LIE
17/08/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/08/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
17/08/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/08/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/05/2016
GNFR
FINAL REFUSAL E-MAILED
09/05/2016
CNFR
FINAL REFUSAL WRITTEN
09/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/04/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/04/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/04/2016
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
20/10/2015
GPRA
PRIORITY ACTION E-MAILED
20/10/2015
CPRA
PRIORITY ACTION WRITTEN
20/10/2015
DOCK
ASSIGNED TO EXAMINER
12/10/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
08/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2015
NWAP
NEW APPLICATION ENTERED
04/07/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace Q2 SOLUTIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.